TPG Biotech
Venture capital · San Francisco, California, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
3Deep-tech portfolio1 active
2Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Avalyn Pharma
25Co-investorsShare a portfolio company
Portfolio · 3 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Prelude Therapeutics | Biotech | Active | Aug 28, 2020 | $97.0M |
| Avalyn Pharma | Biotech | Public | Oct 10, 2023 | $242.4M |
| Passage Bio | Biotech | Public | Sep 6, 2019 | $110.0M |
Peer ranks
Portfolio size#136
Portfolio exits#103
Raises, 12 months#88
Co-investors#79
Co-investors
- BioAdvanceVenture capital2 shared
- Boxer CapitalVenture capital2 shared
- Deerfield Capital ManagementVenture capital2 shared
- Frazier Healthcare PartnersVenture capital2 shared
- Perceptive AdvisorsVenture capital2 shared
- Perceptive Life SciencesVenture capital2 shared
- Quaker BioVenturesVenture capital2 shared
- Third Rock VenturesVenture capital2 shared
- Altitude Life Science VenturesVenture capital1 shared
- Ascent Biomedical VenturesVenture capital1 shared
Sectors
- Biotech3
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.